Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: Delineation of epithelial phenotype
- 1 July 1994
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 173 (3) , 213-219
- https://doi.org/10.1002/path.1711730303
Abstract
The distribution of the two trefoil peptides pS2 and human spasmolytic polypeptide (hSP) and their mRNAs was investigated in 90 selected oesophageal biopsies, 23 of which contained epithelium with wholly gastric cardiac-type morphology, 52 specialized (intestinal)-type metaplasia, and 15 non-metaplastic oesophageal epithelium. No fundic-type epithelium was represented. The cardiac-type epithelium resembled true gastric antral epithelium, with hSP and pS2 mRNA localization to the superficial/foveolar compartment and hSP mRNA alone in deeper glands. The pattern of peptide distribution was broadly in line with the mRNA, but hSP peptide was generally not demonstrable in the surface epithelium. pS2 immunostaining was diffusely cytoplasmic, whereas in specialized-type mucosa it was aggregated and cytoplasmic hSP mRNA was demonstrable in surface epithelium of incomplete- but not complete-type intestinal (specialized) metaplasia. Deep glands with morphological features of pyloric glands/ulcer-associated cell lineage (UACL) typically contained only hSP peptide and its mRNA. In three biopsies containing specialized epithelium, small foci morphologically identical to true small intestinal surface epithelium were seen in which only pS2 mRNA and peptide were found and then only in rare goblet cells. Neither squamous epithelium nor oesophageal glands contained demonstrable pS2/hSP mRNA or peptide. The function of these proteins in the metaplastic mucosa of Barrett's oesophagus is unknown but they may reflect an epithelium responding to repeated insult. Their localization facilitates definition of the disparate epithelium types seen in this portion of the gut, with both native gastric and intestinal epithelia, and may help to pinpoint high-risk epithelium in Barrett's oesophagus, a potentially preneoplastic condition.Keywords
This publication has 15 references indexed in Scilit:
- Pancreatic Spasmolytic Polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreasPublished by Elsevier ,2003
- The amino acid sequence of pancreatic spasmolytic polypeptidePublished by Elsevier ,2003
- The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in ‘gastric metaplasia’ of the proximal duodenum: Implications for the nature of ‘gastric metaplasia’The Journal of Pathology, 1993
- NeoplasiaGut, 1992
- Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissuesThe Journal of Pathology, 1990
- Pancreatic Spasmolytic Polypeptide, a Potential Growth Factor for the Intestine: Neural Control of SecretionDigestion, 1990
- Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cellsNature, 1990
- Revised amino acid sequence of pancreatic spasmolytic polypeptide exhibits greater similarity with an inducible pS2 peptide found in a human breast cancer cell lineBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cellsFEBS Letters, 1989
- Breast Cancer-Associated pS2 Protein: Synthesis and Secretion by Normal Stomach MucosaScience, 1988